Tests chemotherapy drugs directly on a patient's fresh tumor tissue to see which ones the cancer responds to.
Consented intake · your records travel with you · nothing moves without your sign-off
Cordgenics ChemoID is a functional test that applies drugs to fresh tumor tissue and observes the response, with turnaround from two days to six weeks. It is designed to give greater confidence that a patient will respond to a drug or combination before treatment begins. Obtaining fresh tumor tissue can be a limitation, which patients should plan for.
Prefer the source? Cordgenics ChemoID (chemo sensitivity)'s own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Cordgenics ChemoID (chemo sensitivity) handles billing.
We don't have confirmed insurance details for Cordgenics ChemoID (chemo sensitivity) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Cordgenics's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.